Takami, Taro

Publishing since 1974 (Dinosaur)

Has published 102 publications in 36 years

Number of publications published per year by Takami, Taro. (Source : PubMed)

Distribution of publications types for Takami, Taro. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Hara T, Tsurumi H, Goto N, Kanemura N, Yoshikawa T, Kasahara S, Yamada T, Sawada M, Goto H, Fukuno K, Kitagawa J, Yasuda I, Katsumura N, Takemura M, Takahashi T, Takami T, Moriwaki H. Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP.  J. Cancer Res. Clin. Oncol.  2009;135;10  
•  Hara T, Tsurumi H, Goto N, Kitagawa JI, Kanemura N, Yoshikawa T, Kasahara S, Goto H, Fukuno K, Yamada T, Sawada M, Yasuda I, Katsumura N, Takahashi T, Takami T, Moriwaki H. Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma.  J. Cancer Res. Clin. Oncol.  2009  
•  Okada M, Saio M, Kito Y, Ohe N, Yano H, Yoshimura S, Iwama T, Takami T. Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1.  Int. J. Oncol.  2009;34;6  
•  Iwashita T, Yasuda I, Tsurumi H, Goto N, Nakashima M, Doi S, Hirose Y, Takami T, Moriwaki H. Endoscopic ultrasound-guided fine needle aspiration biopsy for splenic tumor: a case series.  Endoscopy  2009;41;2  
•  Takami T, Shioyama S, Fujii K, Goto R, Kuno T. Qualitative and relative quantitative analysis of urinary components with linear ion trap and FT ICR mass spectrometer to search for biomarkers.  Kobe J Med Sci  2009;54;5  
•  Iwashita T, Yasuda I, Doi S, Nakashima M, Tsurumi H, Hirose Y, Takami T, Enya M, Mukai T, Ohnishi T, Iwata K, Tomita E, Moriwaki H. Endoscopic ultrasound-guided fine-needle aspiration in patients with lymphadenopathy suspected of recurrent malignancy after curative treatment.  J. Gastroenterol.  2009;44;3  
•  Kitagawa J, Hara T, Tsurumi H, Goto N, Kanemura N, Yoshikawa T, Kasahara S, Yamada T, Sawada M, Takahashi T, Shimizu M, Takami T, Moriwaki H. Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U).  J. Cancer Res. Clin. Oncol.  2009;135;1  
•  Hara T, Tsurumi H, Kato T, Imao Y, Kojima Y, Kojima K, Kitagawa J, Katsumura N, Araki H, Takami T, Moriwaki H. Immunoproliferative small intestinal disease with protein loss complicated with duodenal T cell lymphoma during progression.  Intern. Med.  2008;47;4  
•  Takami T, Kaposi-Novak P, Uchida K, Gomez-Quiroz LE, Conner EA, Factor VM, Thorgeirsson SS. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.  Cancer Res.  2007;67;20  
•  Yukinaga H, Takami T, Shioyama SH, Tozuka Z, Masumoto H, Okazaki O, Sudo K. Identification of cytochrome P450 3A4 modification site with reactive metabolite using linear ion trap-Fourier transform mass spectrometry.  Chem. Res. Toxicol.  2007;20;10  

[ See timeline ] [ See all publications ]